Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

12.14

Margin Of Safety %

18

Put/Call OI Ratio

0.23

EPS Next Q Diff

0.16

EPS Last/This Y

0.03

EPS This/Next Y

0.47

Price

28.06

Target Price

32.67

Analyst Recom

2

Performance Q

6.13

Relative Volume

0.52

Beta

0.78

Ticker: AMPH




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-08-15AMPH29.840.171.171725
2025-08-18AMPH29.760.210.421295
2025-08-19AMPH30.320.220.001370
2025-08-20AMPH29.60.220.091386
2025-08-21AMPH29.670.220.001386
2025-08-22AMPH30.490.210.001391
2025-08-25AMPH29.830.210.081399
2025-08-26AMPH30.370.210.171406
2025-08-27AMPH30.490.210.001420
2025-08-28AMPH30.250.210.001431
2025-08-29AMPH30.630.19999.991413
2025-09-02AMPH30.810.220.051453
2025-09-03AMPH29.390.220.031450
2025-09-04AMPH29.190.220.001453
2025-09-05AMPH29.470.220.001459
2025-09-08AMPH29.310.22999.991461
2025-09-09AMPH29.350.230.751470
2025-09-10AMPH28.380.231.501475
2025-09-11AMPH28.690.230.671475
2025-09-12AMPH28.050.230.291479
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-08-15AMPH29.83-9.9- 3.32
2025-08-18AMPH29.77-9.9- 3.32
2025-08-19AMPH30.33-12.0- 3.30
2025-08-20AMPH29.60-12.0- 3.30
2025-08-21AMPH29.67-12.0- 3.30
2025-08-22AMPH30.50-12.0- 3.30
2025-08-25AMPH29.84-12.0- 3.30
2025-08-26AMPH30.34-12.0- 3.30
2025-08-28AMPH30.26-11.3- 3.32
2025-08-29AMPH30.61-11.3- 3.32
2025-09-02AMPH30.81-11.3- 3.32
2025-09-03AMPH29.40-11.3- 3.32
2025-09-04AMPH29.22-11.3- 3.32
2025-09-05AMPH29.42-11.3- 3.32
2025-09-08AMPH29.26-11.3- 3.32
2025-09-09AMPH29.28-11.3- 3.32
2025-09-10AMPH28.40-11.3- 3.32
2025-09-11AMPH28.68-11.3- 3.32
2025-09-12AMPH28.06-11.3- 3.32
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-08-15AMPH-0.06-6.2911.80
2025-08-18AMPH-0.06-4.1211.80
2025-08-19AMPH-0.06-4.1211.76
2025-08-20AMPH-0.06-4.1211.76
2025-08-21AMPH-0.06-4.1211.76
2025-08-22AMPH-0.06-4.1211.76
2025-08-25AMPH-0.06-1.7311.76
2025-08-26AMPH-0.06-1.7311.76
2025-08-27AMPH-0.06-1.7312.08
2025-08-28AMPH-0.06-1.7312.08
2025-08-29AMPH-0.06-1.7312.08
2025-09-02AMPH-0.06-1.7012.08
2025-09-03AMPH-0.07-1.7012.08
2025-09-04AMPH-0.07-1.7012.08
2025-09-05AMPH-0.07-1.7012.08
2025-09-08AMPH-0.02-1.7412.08
2025-09-09AMPH-0.02-1.7412.08
2025-09-10AMPH-0.02-1.7412.08
2025-09-11AMPH-0.02-1.7412.14
2025-09-12AMPH-0.02-1.7412.14
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.75

Avg. EPS Est. Current Quarter

0.85

Avg. EPS Est. Next Quarter

0.91

Insider Transactions

-0.02

Institutional Transactions

-1.74

Beta

0.78

Average Sales Estimate Current Quarter

186

Average Sales Estimate Next Quarter

195

Fair Value

33.21

Quality Score

87

Growth Score

92

Sentiment Score

35

Actual DrawDown %

58.5

Max Drawdown 5-Year %

-68.3

Target Price

32.67

P/E

10.51

Forward P/E

7.4

PEG

4.89

P/S

1.81

P/B

1.72

P/Free Cash Flow

11.63

EPS

2.67

Average EPS Est. Cur. Y​

3.32

EPS Next Y. (Est.)

3.79

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

18.64

Relative Volume

0.52

Return on Equity vs Sector %

-7.1

Return on Equity vs Industry %

10

EPS 1 7Days Diff

EPS 1 30Days Diff

0.19

EBIT Estimation

Amphastar Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 2028
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a nasal spray for the treatment of severe hypoglycemia; Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin to prevent and treat deep vein thrombosis; REXTOVY and Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products; morphine injection for use with patient-controlled analgesia pumps; and Lorazepam injection for surgery and medical procedures. In addition, it offers Neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; Isoproterenol hydrochloride injection for mild or transient episodes of heart block; Ganirelix Acetate injection for the inhibition of premature luteinizing hormone surges; Vasopressin to increase blood pressure; and Regadenoson, a stress agent for radionuclide myocardial perfusion imaging, as well as Albuterol Sulfate inhalation aerosol. Further, the company distributes recombinant human insulin APIs and porcine insulin API. Additionally, it develops generic product candidates, such as injectable, inhalation, and analytical technologies; biosimial product candidates; and intranasal epinephrine for the treatment of allergic reactions. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
stock quote shares AMPH – Amphastar Pharmaceuticals Inc Stock Price stock today
news today AMPH – Amphastar Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch AMPH – Amphastar Pharmaceuticals Inc yahoo finance google finance
stock history AMPH – Amphastar Pharmaceuticals Inc invest stock market
stock prices AMPH premarket after hours
ticker AMPH fair value insiders trading